{'fraction_non_alphanumeric': 0.0210727969348659, 'fraction_numerical': 0.0, 'mean_word_length': 6.0675675675675675, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Sarcopenia negatively impacts long‐term outcomes following curative resection for hepatocellular carcinoma: Results of a long‐term follow‐up study

Sarcopenia is a surrogate marker of frailty and is common in cirrhosis. Although sarcopenia is associated with worse outcomes following liver transplantation, its long‐term impact following hepatectomy for hepatocellular carcinoma (HCC) is less well known. We evaluated the prevalence and prognostic impact of sarcopenia in a cohort of patients undergoing resection for HCC.